<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03531853</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00092968</org_study_id>
    <nct_id>NCT03531853</nct_id>
  </id_info>
  <brief_title>OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers</brief_title>
  <official_title>OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and demonstrate new technologies that will enable a
      non-contact, compact eye imaging system based on OCT to assist an early responder in acute
      care settings (like an emergency room) to help assess eye trauma and inflammation (swelling
      inside the eye).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance</measure>
    <time_frame>Up to 18 months</time_frame>
    <description>By the ability to detect cells in the eye compared to clinical exam</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>Imaging patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Get uveitis patients and ER patients to image their eyes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hand-held swept source optical coherence tomography</intervention_name>
    <description>images the eye</description>
    <arm_group_label>Imaging patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Pre-clinical: employees or students (over the age of 18) of the Duke Eye Center or
        Biomedical Engineering willing to be imaged with OCT system

        - Pilot (ER): patients (over the age of 18) presenting emergently to the Duke Emergency
        room with traumatic eye injuries and/or suspected open globe

        - Pilot (Uveitis): patients presenting to the Duke Eye Center with active uveitis and
        microhyphema or hyphema; patients who have independently consented to undergo vitreous tap
        or biopsy for their uveitis care at the Duke Eye Center

        Exclusion Criteria:

        - Pre-clinical: subject cannot be a direct report to any of the PIs or other key personnel
        of this study

        - Pilot (ER): hemodynamically unstable, unable to consent

        - Pilot (Uveitis): unable to consent; cornea or lens opacity/scar which would block the
        imaging modality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Kuo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teresa Hawks</last_name>
    <phone>919-681-1569</phone>
    <email>teresa.hawks@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Hawks</last_name>
      <phone>919-681-1569</phone>
      <email>teresa.hawks@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

